/ /

  • linkedin
  • Increase Font
  • Sharebar

    Glaucoma 360 approaches disease from every angle

    Annual three-day event celebrates, innovates, educates in quest for a cure

    Research. Industry. Philanthropy. These three facets—each with a unique purpose—will come together for the 2017 installment of the annual Glaucoma Research Foundation (GRF) Glaucoma 360 meeting.

    The three-day event, Feb. 2 to 4, will combine a philanthropic gala, a day-long review of the latest innovations in industry, and a half-day of continuing medical education for ophthalmologists.

    “This is unlike any other meeting in that it brings together all the different players involved in preventing and treating glaucoma,” said Tom Brunner, president and chief executive officer of the foundation.

    All events—co-chaired and co-founded by Andrew Iwach, MD, and Adrienne Graves, PhD—will take place at San Francisco’s historic Palace Hotel.

    Dr. Iwach summarized the mission for the trio of events as “we celebrate, we innovate, and then we educate.”

    Ophthalmology Times is a sponsor for the event.


    Adrienne Graves and Andrew Iwach discuss Glaucoma 360 from Glaucoma Research on Vimeo.


    Annual gala

    As in previous years, the meeting will kick off Thursday evening, Feb. 2, with the Glaucoma 360 Annual Gala. This annual benefit will showcase the visionaries and catalysts who share GRF’s mission to prevent vision loss from glaucoma by investing in innovative research, education, and support with the ultimate goal of finding a cure, according to the organization. To date, more than $3 million has been raised from this event to for- ward research, education, and support programs.

    During this event, the 2017 Shaffer Prize for Innovative Glaucoma Research will be presented to Richard T. Libby, PhD, associate professor, Department of Ophthalmology, University of Rochester Medical School, Rochester, NY, for his research project titled “Understanding Axonal Degeneration Pathways in Glaucoma.”

    Also, Eugene de Juan Jr., MD, holder of the Jean Kelly Stock Distinguished Chair in Ophthalmology, University of California-San Francisco, will receive The Catalyst Award. As a retina specialist, entrepreneur, philanthropist, and educator, Dr. de Juan “has made a real difference in this field,” Brunner said.

    Gala tickets are $495 per person, which includes dinner, silent and live auctions, entertainment, and research progress reports. Proceeds will help fund glaucoma research.

    New Horizons Forum

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results